<DOC>
	<DOCNO>NCT01972204</DOCNO>
	<brief_summary>The purpose study examine influence instruction use Aricept educational brochure 48-week medication persistence ass reason discontinuation .</brief_summary>
	<brief_title>Intensive Instruction Use Aricept</brief_title>
	<detailed_description />
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Diagnostic evidence probable Alzheimer 's type Dementia consistent DSMIV . Written inform consent obtain subject ( possible ) subject 's legal guardian representative ( accord Japanese regulation appropriate ) prior begin screen activity . Patients caregiver submit write consent cooperative involvement study , provide patient ' information necessary study , assist treatment compliance , escort patient require visit study institution . Outpatients home . Patients treat donepezil , galantamine , rivastigmine 4 week immediately enrollment . Known hypersensitivity donepezil piperidine derivative . Involvement investigational drug clinical trail precede 12 week .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>